OLVIG
GILD icon

Oliver Lagore Vanvalin Investment Group’s Gilead Sciences GILD Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-250
Closed -$17.2K – 714
2024
Q2 		$17.2K Buy
+250
New +$16.7K ﹤0.01% 355
2023
Q3 		– Sell
-30
Closed -$2.31K – 868
2023
Q2 		$2.31K Buy
+30
New +$2.39K ﹤0.01% 643

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Oliver Lagore Vanvalin Investment Group's GILD Position: Q3 2024 in Review

Oliver Lagore Vanvalin Investment Group sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 250 shares — an estimated $17.2K sold.

Oliver Lagore Vanvalin Investment Group first reported a position in GILD in Q2 2023 and held it in 2 quarters. The position peaked at $17.2K in Q2 2024. 1,719 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Oliver Lagore Vanvalin Investment Group reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Oliver Lagore Vanvalin Investment Group sold 250 Gilead Sciences shares in Q3 2024, an estimated $17.2K.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Gilead Sciences in Q2 2023 and held it in 2 quarters.
  • Oliver Lagore Vanvalin Investment Group's Gilead Sciences position peaked at $17.2K in Q2 2024.
  • 1,719 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q3 2024, filed 4 Nov 2024.